Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Guilu Erxian Jiao in the Treatment of Intradialytic Hypotension

NCT06980922 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.

NCT NCT06980922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06980922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Guilu Erxian Jiao in the Treatment of Intradialytic Hypotension
Lead sponsor
Chang Gung Memorial Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
June 1, 2025
Completion date
May 31, 2028
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal disease, hemodialysis, intradialytic hypotension